WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, or diseases of the nerves, and neurovascular diseases, announced today that it is scheduled to present at the Citigroup Healthcare Conference at The Hilton New York in New York City at 4:30 pm (EDT) on Tuesday, May 22, 2007. The audio presentation will be simultaneously available via webcast on the “Investors” home page at http://www.neurometrix.com.
